Skip to Main Content

Asset Allocation Update: Is the tech hibernation coming to an end soon?

US technology stocks are stagnating. However, continuous profit growth is making valuations more attractive. The ongoing earnings season could therefore inject fresh momentum into stock prices. At the same time, cyclical sectors are gaining tailwinds from promising economic data and loose financial conditions. However, sentiment is becoming increasingly euphoric, while the sharp rise in yields in Japan and the impressive rally in precious metals pose potential systemic risks.

Author: Nicola Grass

Krokusse im Schnee
Tech stocks could flourish again after the current quiet phase (Image: iStock.com).

What changes have we made to the portfolios?

Our economists have further raised their economic forecasts for the US (now above 2% for 2026). Additionally, the sharp rise in yields in Japan and the political unrest fuelled by US President Donald Trump could add further selling pressure.

US technology stocks have been moving sideways since last October, while earnings growth remains excellent (US Tech +20% in Q4/25 vs. 1% for US ex Tech). At the same time, valuations (P/E ratio) have decreased (from 28 to 25). We are therefore buying.

After the strong recovery of healthcare stocks in November, momentum has now slowed. Additionally, earnings expectations are being significantly revised downwards. We are therefore selling our tactical position.

Global small caps are attractively valued after significant underperformance. With expected earnings growth of 25% for 2026, supported by lower credit costs and diversification, they offer attractive opportunities compared to other cyclical investments.

Our EM bet is paying off, and the start of the year has been very encouraging. The performance of +6% since the beginning of the year is broadly supported across styles and countries. We are therefore increasing our overweight.

The commodity index BCOM has reached a new all-time high, thanks in part to the sharp rise in natural gas prices by more than 40% since the start of the year. Momentum is strong, and Iran poses risks to oil. We are therefore closing our underweight and remain overweight in gold.

Bonds: Emerging Markets and Australia

Yields on US government bonds have been rising again since the start of the year. The reasons behind this are renewed verbal attacks by US President Donald Trump on Europe and strong economic data. Additionally, the US Supreme Court's decision regarding trade tariffs is pending, which could significantly increase pressure on the federal budget. While we generally find global government bonds attractive at current yield levels, we see more opportunities in emerging markets or Australia. For corporate bonds, we maintain our underweight position and prefer to take risks in equities and convertible bonds, where we see significantly greater upside potential. We also remain heavily underweight in CHF bonds, which we consider to be relatively unattractive. 

Equities: Barbell Strategy repositioned

In recent months, we have followed a barbell strategy focused on tech and pharma. We are now selling pharmaceutical stocks and instead buying global small caps. This move aims to capitalise on the momentum of the cyclical upswing. On the other hand, we are increasing our overweight in the IT sector. Since last October, IT has somewhat fallen out of focus and has been moving sideways. However, as the fundamentals remain very strong, valuations have significantly improved compared to the broader market (chart below). We are also making additional purchases in emerging market equities, which we believe show strong momentum. As a result, we are increasing our equity overweight to 3%.

Source: Bloomberg, Zürcher Kantonalbank

Alternative Investments: A new Supercycle in Commodities?

Precious and industrial metals currently seem to be moving in only one direction: upwards. Now, natural gas prices have also surged due to the cold weather in the US. Given the risks to oil prices stemming from the massive protests in Iran, we no longer want to go against this momentum and are closing our underweight position. For gold, we remain overweight for the time being, although profit-taking is likely to increase as prices approach around $5,000 per ounce.

Our Tactical Asset Allocation (EUR) in February 2026

 

Relative weighting vs. Strategic Asset Allocation (SAA) in % in January and February 2026 (Source: Zürcher Kantonalbank, Asset Management)

Legal notice

“BLOOMBERG®” and the Bloomberg indices listed herein (the “Indices”) are service marks of Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited (“BISL”), the administrator of the Indices (collectively, “Bloomberg”) and have been licensed for use for certain purposes by the distributor hereof (the “Licensee”). Bloomberg is not affiliated with Licensee, and Bloomberg does not approve, endorse, review, or recommend the financial products named herein (the “Products”). Bloomberg does not guarantee the timeliness, accuracy, or completeness of any data or information relating to the Products.

Categories

Investment Strategy